2018
DOI: 10.1002/ajmg.a.60691
|View full text |Cite
|
Sign up to set email alerts
|

Clinical characterization of aPUF60variant in a patient with Dubowitz‐like syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
16
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(19 citation statements)
references
References 24 publications
1
16
0
Order By: Relevance
“…reported in seven patients with VRJS, four of whom are female, a prevalence far above the population rate of 1 in 40 to 1 in 400 individuals and in which there is a known and significant male preponderance (Biavati et al, 2020;El Chehadeh et al, 2017;Isidor & David, 2015;Low et al, 2017) In combining our detailed phenotypic data with the previously reported, and variably phenotyped patients, we further refine the known frequencies of features associated with VRJS (Table 3). These include neurodevelopmental delay/intellectual disability (98%), axial skeletal anomalies (74%), appendicular skeletal anomalies (73%), oral anomalies (68%), short stature (66%), cardiac anomalies (63%), brain malformations (48%), hearing loss (46%), microcephaly (41%), colobomata (38%), and other ocular anomalies (65%) (Alkhunaizi & Braverman, 2019;Dauber et al, 2013;Deciphering Developmental Disorders, 2017;El Chehadeh et al, 2017;Fromer et al, 2014;Graziano et al, 2017;Haug et al, 2021;Isidor & David, 2015;Jourdain et al, 2020;Kernohan et al, 2018;Latypova et al, 2021;Low et al, 2017;Moccia et al, 2018;Santos-Simarro et al, 2017;Q. Xu et al, 2018;Yamada et al, 2020;Zanolli et al, 2020;Zhao et al, 2018).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…reported in seven patients with VRJS, four of whom are female, a prevalence far above the population rate of 1 in 40 to 1 in 400 individuals and in which there is a known and significant male preponderance (Biavati et al, 2020;El Chehadeh et al, 2017;Isidor & David, 2015;Low et al, 2017) In combining our detailed phenotypic data with the previously reported, and variably phenotyped patients, we further refine the known frequencies of features associated with VRJS (Table 3). These include neurodevelopmental delay/intellectual disability (98%), axial skeletal anomalies (74%), appendicular skeletal anomalies (73%), oral anomalies (68%), short stature (66%), cardiac anomalies (63%), brain malformations (48%), hearing loss (46%), microcephaly (41%), colobomata (38%), and other ocular anomalies (65%) (Alkhunaizi & Braverman, 2019;Dauber et al, 2013;Deciphering Developmental Disorders, 2017;El Chehadeh et al, 2017;Fromer et al, 2014;Graziano et al, 2017;Haug et al, 2021;Isidor & David, 2015;Jourdain et al, 2020;Kernohan et al, 2018;Latypova et al, 2021;Low et al, 2017;Moccia et al, 2018;Santos-Simarro et al, 2017;Q. Xu et al, 2018;Yamada et al, 2020;Zanolli et al, 2020;Zhao et al, 2018).…”
Section: Discussionmentioning
confidence: 99%
“…The mutational spectrum of PUF60 includes frameshift, splice‐site, and missense variants. Pathogenic missense variants published to date are located within exons that encode the RRM1 and the UHM binding domains, suggesting that their alteration affects protein function and causes disease (Alkhunaizi & Braverman, 2019; Dauber et al, 2013; El Chehadeh et al, 2017; Graziano et al, 2017; Kernohan et al, 2018; Low et al, 2017; Moccia et al, 2018). PUF60 is homologous to another splicing factor, U2AF65 and RNAseq studies have shown that PUF60 and U2AF65 have opposing effects on exon splicing of many genes with PUF60 appearing to act mainly as an activator of splicing (Kralovicova et al, 2015).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The minimal common deletion found encompassed 3 genes including SCRIB and PUF60 and displayed most of the cardinal features of VRJS 29 . Although PUF60 appears to be a major driver of VRJS syndrome 29,[57][58][59][60][61][62][63][64] , neurological features were reported in a much lower proportion, indicating that PUF60 CNVs may not be their sole cause. From the human genetics standpoint, any VRJS-related phenotype due to SCRIB loss may prove difficult to observe because most SCRIB mutations lead to NTDs so deleterious that they may obscure more "subtle" phenotypes [20][21][22][23] .…”
Section: Discussionmentioning
confidence: 97%
“…Among 32 patients who were reported to have deletions or de novo pathogenic variants of PUF60 (MIM#604819), the degree of clinical severity was relatively diverse, and no apparent genotype–phenotype correlations have been described so far (Alkhunaizi & Braverman, 2019; Dauber et al, 2013; El Chehadeh et al, 2016; Graziano et al, 2017; Low et al, 2017; Moccia et al, 2018; Santos‐Simarro et al, 2017; Verheij et al, 2009; Xu et al, 2018; Zhao et al, 2018). The PUF60 protein has two central RNA recognition motifs, RRM1 and RRM2, and a C′ terminal UHM (U2AF‐homology motif) motif (Corsini et al, 2009).…”
Section: Introductionmentioning
confidence: 99%